- Home
- Oncology
Oncology
We listen and learn with compassion to understand the needs of patients, caregivers, and healthcare professionals who remind us every day why we are working toward this bold ambition.
Cancer remains a leading cause of death globally. In 2022 alone, 20 million people worldwide were diagnosed with cancer, and almost 10 million died of the disease. With more than a three-decade legacy in oncology innovation, our commitment to pioneer new therapeutic advances for patients with cancer has never been stronger.
Cancer remains a leading cause of death globally. In 2022 alone, 20 million people worldwide were diagnosed with cancer, and almost 10 million died of the disease. With more than a three-decade legacy in oncology innovation, our commitment to pioneer new therapeutic advances for patients with cancer has never been stronger.
At Johnson & Johnson, our focus is singular—eliminate cancer.
Disease areas
Innovation
-
Conquering complex biologyJ&J discovers novel targets, develops new therapies, and progresses earlier lines of therapy, regimens, and combinations. -
Data science & AIFrom target discovery and patient segmentation to drug design and chemistry, manufacturing and controls process optimization, J&J uses data science and AI to accelerate all facets of clinical development. -
Global Centers of Excellence (COE)COEs include biomarkers, companion diagnostics, biologics, and precision medicine, which are further enhanced by local expertise in regulatory and medical affairs.
Learn more
Resources
